Emergent BioSolutions Refinances Term Loan and Amends ABL Facility
Emergent BioSolutions closed on a new credit facility agreement with OrbiMed for a new $150 million term loan. The proceeds from the new term loan were used to repay all amounts outstanding under the previous term loan facility agreement with...
Read moreDetails









